Clinical Trial Update: Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates mesenchymal stem cells are being included with the OrthADAPT Membrane for repairing rotator cuff tears.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)
• OrthADAPT Membrane

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Chronic Disease | Phase 2 | Status: UNKNOWN